Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ionotropic glutamate receptor AMPA subtype, commonly known as the AMPA receptor (AMPAR), is a tetrameric ligand-gated ion channel widely distributed in the central nervous system and is responsible for fast excitatory synaptic transmission. Activated by glutamate binding, AMPARs allow the influx of sodium and, in some cases, calcium ions, leading to neuronal depolarization. The receptor consists of four subunits (GluA1–GluA4), often co-assembled, and interacts with auxiliary proteins such as TARPs and cornichon homologs, which modulate its trafficking, gating, and pharmacology. Dysfunction or altered regulation of AMPARs is implicated in numerous brain disorders, making them important therapeutic targets for epilepsy, neurodegenerative diseases, psychiatric illness, and ischemic injury[1][2][4][5].
Noncompetitive antagonism, Competitive antagonism, Allosteric modulation, Channel block
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ionotropic glutamate receptor AMPA subtype (AMPA receptor (AMPAR)).